GGTI-2133,
N-(4-(imidazol-4-yl)methylamino)-2-(1-(naphthyl)benzolyl)leucine trifluoroacetate salt,
GGTI-2133,
CHEMBL26246,
191102-79-1,
4-[[N-(Imidazol-4-yl)methyleneamino]-2-(1-naphthyl)benzoyl]leucine,
GGTI 2133 free base,
GGTI-2133 free base,
SCHEMBL4280385,
SCHEMBL16111812,
CHEBI:101257,
GGTI 2133,
BCP28571,
BDBM50076135,
ZINC13796731,
NCGC00165801-01,
N-[4-{[(1H-imidazol-4-yl)methyl]amino}-2-(naphthalen-1-yl)benzoyl]-L-leucine,
(2S)-2-(4-((1H-imidazol-4-yl)methylamino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoic acid,
(S)-2-{4-[(1H-Imidazol-4-ylmethyl)-amino]-2-naphthalen-1-yl-benzoylamino}-4-methyl-pentanoic acid,
CID9846868,
C547856,
N-(4-(imidazol-4-yl)methylamino)-2-(1-(naphthyl)benzolyl)leucine trifluoroacetate salt,
(2S)-2-[[4-(3H-imidazol-4-ylmethylamino)-2-naphthalen-1-yl-benzoyl]amino]-4-methyl-pentanoic Acid,